ARTICLE | Finance
Imperial's diagnostic push
Why Imperial plans to boost diagnostic, medtech investing
February 15, 2016 8:00 AM UTC
Imperial Innovations Group plc (LSE:IVO) is looking to put a fresh £100 million to work to follow its existing portfolio companies and create newcos, with an increasing emphasis on diagnostics and medtech.
The firm has already started ramping up, with its largest-ever diagnostics investment, in Inivata Ltd. Inivata is developing TAm-Seq circulating tumor DNA (ctDNA) analysis technology as a non-invasive blood test with an initial focus on solid tumor diagnostics...